Skip to content
GenoLensGenoLens

PTPN11

Chr 12q24.13

protein tyrosine phosphatase non-receptor type 11

Aliases:
BPTP3, SH-PTP2, SHP-2, PTP2C, SHP2
MANE:
ENST00000351677.7

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Adult solid tumours cancer susceptibility

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Childhood solid tumours

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Childhood solid tumours cancer susceptibility

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • DDG2P

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Embryonal tumour of possible germline origin

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal anomalies

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Fetal hydrops

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Haematological malignancies cancer susceptibility

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

+21 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • Noonan syndrome

    0.88
  • Noonan syndrome with multiple lentigines

    0.84
  • juvenile myelomonocytic leukemia

    0.83
  • LEOPARD syndrome 1

    0.77
  • metachondromatosis

    0.77
  • acute myeloid leukemia

    0.64
  • cancer

    0.61
  • RASopathy

    0.59
  • Noonan syndrome and Noonan-related syndrome

    0.57
  • Abnormality of the cardiovascular system

    0.57

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Tyrosine-protein phosphatase non-receptor type 11

Acts downstream of various receptor and cytoplasmic protein tyrosine kinases to participate in the signal transduction from the cell surface to the nucleus (PubMed:10655584, PubMed:14739280, PubMed:18559669, PubMed:18829466, PubMed:26742426, PubMed:28074573, PubMed:32184441). Positively regulates MAPK signal transduction pathway (PubMed:28074573). Dephosphorylates GAB1, ARHGAP35 and EGFR (PubMed:28074573). Dephosphorylates ROCK2 at 'Tyr-722' resulting in stimulation of its RhoA binding activity (PubMed:18559669). Dephosphorylates CDC73 (PubMed:26742426). Dephosphorylates SOX9 on tyrosine residues, leading to inactivate SOX9 and promote ossification (By similarity). Dephosphorylates tyrosine-phosphorylated NEDD9/CAS-L (PubMed:19275884). Acts as an effector of PDCD1-mediated inhibition of T-cell response: recruited by phosphorylated PDCD1, mediating dephosphorylation of key T-cell receptor (TCR) proximal signaling molecules, leading to TCR signaling inhibition (PubMed:32184441)

Curated MONDO disease pages that list PTPN11 among their top associated genes.

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.